NovaBridge Biosciences ADR
NovaBridge Biosciences ADR (NBP) Straddle
No qualifying straddle setups were found for NBP in the prior session.
Read more
Trading a NBP straddle lets you take a pure volatility position on NovaBridge Biosciences ADR without committing to a direction. NovaBridge Biosciences ADR's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate NBP straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on NBP profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when NovaBridge Biosciences ADR stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the NBP straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
NovaBridge Biosciences, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is developing givastomig, a bispecific antibody, which is in Phase 1b clinical trial for the treatment of gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, a bispecific antibody, which is in phase 1 clinical trial for the treatment of solid tumors. It has a strategic licensing agreement with Ferring International Center SA to research, develop, make, have made, import, use, sell, and offer to sell FE301, an interleukin-6 inhibitor.
The company also has collaborations with Bristol Myers Squibb for the development of givastomig; ABL Bio, Inc. for the development of givastomig and ragistomig; and TJ Bio for the development of uliledlimab. The company was formerly known as I-Mab and change its name to NovaBridge Biosciences in October 2025. NovaBridge Biosciences was founded in 2014 and is headquartered in Rockville, Maryland.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the NBP straddle is the cleanest expression of that view. Our scanner prices every NBP straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a NBP straddle into a catalyst or short a NBP straddle to harvest decay, the options straddle setups that matter are all in one place.
No illustrative rows to display.
As of October 5, 2026
Find the right straddle before volatility moves
Track NBP straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.
Start your 14-day free trial→